Skip to content

Clinical Efficacy Study of Tiaoshen Huatan Acupuncture in Treating Insomnia Complicated by Borderline Elevated Blood Lipids

Clinical Efficacy Study of Tiaoshen Huatan Acupuncture in Treating Insomnia Complicated by Borderline Elevated Blood Lipids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000845
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-05-10
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Complicated by Borderline Elevated Blood Lipids

Interventions

TiaoShen HuaTan Acupuncture Group:Health Guidance on Sleep Diet and Exercise Combined with TiaoShen HuaTan Acupuncture Therapy (6-week regimen)
Sham Acupuncture Group:Health Guidance on Sleep Diet and Exercise Combined with Sham Acupuncture Therapy (6-week regimen)

Sponsors

Beijing Hospital of Traditional Chinese Medicine Capital Medical University?
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria?? ??Diagnosis confirmation??: Met diagnostic criteria for both chronic insomnia and borderline-elevated blood lipids with reference to: Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) Chinese Guideline for Diagnosis and Treatment of Insomnia in Adults (2023 Edition) Chinese Guideline for Lipid Management (2023) ??Lipid thresholds?? (applicable to low-risk ASCVD primary prevention population in China): LDL-C =3.4 and 7 ??Treatment history??: No lipid-lowering therapies within the preceding 3 months ??Ethical compliance??: No participation in other clinical trials during the prior 3 months Voluntarily signed informed consent after comprehensive understanding of trial procedures potential risks and benefits

Exclusion criteria

Exclusion criteria: Exclusion Criteria?? ??Psychiatric disorders??: Presence of severe mental health conditions including major depressive disorder generalized anxiety disorder schizophrenia or other psychotic disorders. ??Systemic diseases??: Diagnosis of severe cardiovascular cerebrovascular renal or hepatic pathologies (e.g. NYHA Class III/IV heart failure cirrhosis Child-Pugh C). ??Non-compliance??: Inability to adhere to treatment protocols as determined by baseline assessment. ??Reproductive status??: Individuals who are planning pregnancy currently pregnant or lactating. Participants meeting any of the above criteria were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index(PSQI);

Secondary

MeasureTime frame
Hamilton Anxiety Scale(HAMA);body mass index(BMI);Total Cholesterol(TC)/Triglyceride(TG)/Low-Density Lipoprotein Cholesterol(LDL-C)/High-Density Lipoprotein Cholesterol(HDL-C)/Apolipoprotein B(APoB);

Countries

China

Contacts

Public ContactLu Li

Beijing Hospital of Traditional Chinese Medicine Capital Medical University?

watercolour528@hotmail.com15811529291

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026